ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    INCIDENCE OF URINARY TRACT INFECTION IN PATIENTS TAKING SODIUM-DEPENDENT GLUCOSE COTRANSPORTERS-2 INHIBITORS: A COMPARATIVE STUDY


    Dr. Naman Yadav, Dr. Rajendra Dhar, Dr. Rahul Parashar
    JCDR. 2023: 3774-3780

    Abstract

    Background: New drug classes for treating type 2 Diabetes Mellitus (D.M.) have emerged, such as inhibitors of renal sodium-glucose co-transporter-2 (SGLT2). Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are commonly prescribed anti-hyperglycemic agents worldwide due to extensive evidence supporting their efficacy in controlling hyperglycemia. Despite these benefits, SGLT-2 inhibitors are hypothesized and linked to a higher incidence of urinary tract infections (UTIs). Thus, the United States Food and Drug Administration issued a safety warning for prescribers and patients using SGLT-2 inhibitors in 2015. With this background, a study was planned to determine the incidence of UTIs in patients with Type 2 Diabetes Mellitus.

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 12

    Keywords